Protective effect of an SDF-1 variant in HIV disease: abstract and commentary.
Michael
N L
NL
Department of Molecular Diagnostics and Pathogenesis, Walter Reed Army Institute of Research, Rockville, MD, USA. nmichael@pasteur.hjf.org
D019380:Anti-HIV Agents; D054377:Chemokine CXCL12; D018925:Chemokines / Q000235:genetics*; D019743:Chemokines, CXC; D018450:Disease Progression; D015658:HIV Infections / Q000235:genetics / Q000276:immunology*; D015497:HIV-1 / Q000502:physiology*; D006801:Humans; D011110:Polymorphism, Genetic; D054390:Receptors, CCR2; D019718:Receptors, CXCR4 / Q000235:genetics; D019707:Receptors, Chemokine / Q000235:genetics*
D019380:Anti-HIV Agents; C515334:CCR2 protein, human; C515255:CXCL12 protein, human; D054377:Chemokine CXCL12; D018925:Chemokines; D019743:Chemokines, CXC; D054390:Receptors, CCR2; D019718:Receptors, CXCR4; D019707:Receptors, Chemokine